BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 12, 2006
View Archived Issues
Genentech Earnings: Lucentis Strong, Oncology Weakening
Genentech Inc. beat expectations for the third quarter and posted strong sales of Lucentis, but weaker-than-expected performance from its oncology franchise cast a shadow over the numbers. (BioWorld Today)
Read More
Striking Deals: Balance Of Power Shifting To Biotech?
Read More
Caprion, Centocor Sign Deal To Find Cancer Drug Targets
Read More
Antibacterial Firm Achaogen Gets $26M In Second Round
Read More
Other News To Note
Read More
Clinic Roundup
Read More